China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase 1 Study of DEC003M, an Antibody Drug Conjugate Targeting PSMA, for Advanced Stage Prostate Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130230
Registration Time: 2026/08/17
Type: Interventional study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332715
Published by HT Digital Content Services with permission from Health Daily Digest....